Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
CLN-978 by Cullinan Therapeutics for Follicular Lymphoma: Likelihood of Approval
CLN-978 is under clinical development by Cullinan Therapeutics and currently in Phase II for Follicular Lymphoma. According to GlobalData, Phase...
Data Insights
CLN-978 by Cullinan Therapeutics for Mantle Cell Lymphoma: Likelihood of Approval
CLN-978 is under clinical development by Cullinan Therapeutics and currently in Phase II for Mantle Cell Lymphoma. According to GlobalData,...